159 related articles for article (PubMed ID: 30125647)
1. The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program.
Kaye DR; Ye Z; Li J; Herrel LA; Dupree JM; Ellimoottil C; Miller DC
Urology; 2019 Jan; 123():114-119. PubMed ID: 30125647
[TBL] [Abstract][Full Text] [Related]
2. Episode-based Payment Variation for Urologic Cancer Surgery.
Ellimoottil C; Li J; Ye Z; Dupree JM; Min HS; Kaye D; Herrel LA; Miller DC
Urology; 2018 Jan; 111():78-85. PubMed ID: 29051001
[TBL] [Abstract][Full Text] [Related]
3. Variation in Physician-Specific Episode Payments for Major Cancer Surgery and Implications for the Merit-Based Incentive Program.
Kaye DR; Dunn RL; Li J; Herrel LA; Dupree JM; Miller DC; Ellimoottil C
J Surg Res; 2019 Apr; 236():30-36. PubMed ID: 30694769
[TBL] [Abstract][Full Text] [Related]
4. Outcomes for urologic oncology procedures: are there differences between academic and community hospitals?
Syed JS; Abello A; Nguyen J; Lee AJH; Desloges JJ; Leapman MS; Kenney PA
World J Urol; 2020 May; 38(5):1187-1193. PubMed ID: 31420696
[TBL] [Abstract][Full Text] [Related]
5. Hospital-level variation in the quality of urologic cancer surgery.
Gore JL; Wright JL; Daratha KB; Roberts KP; Lin DW; Wessells H; Porter M
Cancer; 2012 Feb; 118(4):987-96. PubMed ID: 21792864
[TBL] [Abstract][Full Text] [Related]
6. Use and outcomes of extended antibiotic prophylaxis in urological cancer surgery.
Calvert JK; Holt SK; Mossanen M; James AC; Wright JL; Porter MP; Gore JL
J Urol; 2014 Aug; 192(2):425-9. PubMed ID: 24603103
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and critique of the literature relating hospital or surgeon volume to health outcomes for 3 urological cancer procedures.
Nuttall M; van der Meulen J; Phillips N; Sharpin C; Gillatt D; McIntosh G; Emberton M
J Urol; 2004 Dec; 172(6 Pt 1):2145-52. PubMed ID: 15538220
[TBL] [Abstract][Full Text] [Related]
8. Intra-operative cell salvage in urological surgery: a systematic review and meta-analysis of comparative studies.
Kinnear N; O'Callaghan M; Hennessey D; Liddell H; Newell B; Bolt J; Lawrentschuk N
BJU Int; 2019 Feb; 123(2):210-219. PubMed ID: 29726092
[TBL] [Abstract][Full Text] [Related]
9. Anesthesia for radical prostatectomy, cystectomy, nephrectomy, pheochromocytoma, and laparoscopic procedures.
Whalley DG; Berrigan MJ
Anesthesiol Clin North Am; 2000 Dec; 18(4):899-917, x. PubMed ID: 11094697
[TBL] [Abstract][Full Text] [Related]
10. Inequity in selective referral to high-volume hospitals for genitourinary malignancies.
Berg S; Tully KH; Sahraoui A; Tan WS; Krimphove MJ; Marchese M; Lipsitz SR; Noldus J; Trinh QD
Urol Oncol; 2020 Jun; 38(6):582-589. PubMed ID: 32217041
[TBL] [Abstract][Full Text] [Related]
11. Association of Comorbidity, Age, and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
Adejoro O; Alishahi A; Konety B
Urology; 2016 Nov; 97():130-137.e1. PubMed ID: 27397095
[TBL] [Abstract][Full Text] [Related]
12. The Sunshine Act and oncology: Lessons learned from urology.
Maruf M; Agarwal PK; Sidana A
Semin Oncol; 2017 Aug; 44(4):265-266. PubMed ID: 29526254
[TBL] [Abstract][Full Text] [Related]
13. Identification of underserved areas for urologic cancer care.
Mossanen M; Izard J; Wright JL; Harper JD; Porter MP; Daratha KB; Holt SK; Gore JL
Cancer; 2014 May; 120(10):1565-71. PubMed ID: 24523042
[TBL] [Abstract][Full Text] [Related]
14. Identifying Drivers of Episode Cost Variation With Radical Prostatectomy.
Herrel LA; Syrjamaki JD; Linsell SM; Miller DC; Dupree JM
Urology; 2016 Nov; 97():105-110. PubMed ID: 27496300
[TBL] [Abstract][Full Text] [Related]
15. Mortality after urologic cancer surgery: impact of non-index case volume.
Gilbert SM; Dunn RL; Miller DC; Daignault S; Ye Z; Hollenbeck BK
Urology; 2008 May; 71(5):906-10. PubMed ID: 18372016
[TBL] [Abstract][Full Text] [Related]
16. Financial Margins for Prostate Cancer Surgery: Quantifying the Impact of Modifiable Cost Inputs in an Episode Based Reimbursement Model.
Johnson DC; Kwok E; Ahn C; Pashchinskiy A; Laviana AA; Golla V; Rosenthal JT; Bravo F; Litwin MS; Saigal CS
J Urol; 2019 Sep; 202(3):539-545. PubMed ID: 31009291
[TBL] [Abstract][Full Text] [Related]
17. Physician and facility drivers of spending variation in locoregional prostate cancer.
Rodin D; Chien AT; Ellimoottil C; Nguyen PL; Kakani P; Mossanen M; Rosenthal M; Landrum MB; Sinaiko AD
Cancer; 2020 Apr; 126(8):1622-1631. PubMed ID: 31977081
[TBL] [Abstract][Full Text] [Related]
18. The diminishing returns of robotic diffusion: complications after robot-assisted radical prostatectomy.
Sammon JD; Abdollah F; Klett DE; Pucheril D; Sood A; Trinh QD; Menon M
BJU Int; 2016 Feb; 117(2):211-2. PubMed ID: 25754061
[No Abstract] [Full Text] [Related]
19. [Laparoscopy in the treatment of urologic cancers].
Vallancien G; Cathelineau X; Barret E; Rozet F
Bull Cancer; 2007 Dec; 94(12):1072-4. PubMed ID: 18156115
[TBL] [Abstract][Full Text] [Related]
20. Variation in Hospital Episode Costs With Bariatric Surgery.
Grenda TR; Pradarelli JC; Thumma JR; Dimick JB
JAMA Surg; 2015 Dec; 150(12):1109-15. PubMed ID: 26376433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
